Related Experiment Video
Updated: Sep 27, 2025

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Emerging role of RNA sensors in tumor microenvironment and immunotherapy
Rui Yang1, Sihui Yu1, Tianhan Xu1
1Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Abstract:
RNA sensors detect foreign and endogenous RNAs to protect the host by initiating innate and adaptive immune response. In tumor microenvironment (TME), activation of RNA sensors induces tumor-inhibitory cytotoxic T lymphocyte responses and inhibits the activity of immunosuppressive cells though stimulating type I IFN signaling pathway. These characteristics allow RNA sensors to be prospective targets in tumor immunotherapy. Therefore, a comprehensive understanding of the roles of RNA sensors in TME could provide new insight into the antitumor immunotherapy. Moreover, RNA sensors could be prominent triggering targets to synergize with immunotherapies. In this review, we highlight the diverse mechanisms of RNA sensors in cancer immunity and their emerging contributions in cancer immunotherapy, including monotherapy with RNA sensor agonists, as well as combination with chemotherapy, radiotherapy, immune checkpoint blockade or cancer vaccine.
Insights
RNA sensors are key players in anti-tumor immunity by activating immune responses within the tumor microenvironment. Targeting these sensors offers promising strategies for enhancing cancer immunotherapy effectiveness.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- RNA sensors are crucial for host defense, initiating innate and adaptive immune responses.
- In the tumor microenvironment (TME), RNA sensor activation promotes anti-tumor immunity and counteracts immunosuppression via type I interferon signaling.
- Understanding RNA sensor roles in the TME is vital for advancing cancer immunotherapy.
Purpose of the Study:
- To review the diverse mechanisms of RNA sensors in cancer immunity.
- To highlight the emerging contributions of RNA sensors in cancer immunotherapy.
- To explore RNA sensors as potential targets for synergistic cancer treatments.
Main Methods:
- Literature review of RNA sensor functions in cancer immunity.
- Analysis of RNA sensor mechanisms in the tumor microenvironment.
- Synthesis of current research on RNA sensors in various cancer immunotherapy strategies.
Main Results:
- RNA sensor activation in TME stimulates cytotoxic T lymphocyte responses.
- Activation of RNA sensors inhibits immunosuppressive cells through type I IFN signaling.
- RNA sensors demonstrate potential as targets for monotherapy and combination treatments.
Conclusions:
- RNA sensors are critical regulators of anti-tumor immunity.
- Targeting RNA sensors presents a promising avenue for novel cancer immunotherapies.
- RNA sensors can synergize with existing treatments like chemotherapy, radiotherapy, and immune checkpoint blockade.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Experimental RNAi
Translational Regulation

